stars 1 stars 2 stars 3

Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. The first product line is the Self Monitoring Blood Glucose (SMBG) System. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patented technology of unique test strip structure. Today, BIONIME employs more than 500 employees and operates 3 subsidiaries in major markets, Europe, America and Asia. Our products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed into the worldwide markets. With the support from our customers, we are confident to grow BIONIME the global competitive leadership in the field of SMBG.

BIONIME GmbH Questions

The BIONIME GmbH annual revenue was $66.5 million in 2026.

1 people are employed at BIONIME GmbH.

BIONIME GmbH is based in Taichung City, Taiwan.

The NAICS codes for BIONIME GmbH are [339, 33, 334].

The SIC codes for BIONIME GmbH are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users